Osimertinib

Osimertinib is indicated for the treatment of adult patients with locally advanced or metastatic epiderm

Tagrix (Osimertinib), generic Tagrisso is a prescription Capsule use to treat advanced or metastatic epidermal growth fa...
12/03/2024

Tagrix (Osimertinib), generic Tagrisso is a prescription Capsule use to treat advanced or metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC). Tagrix manufactured by Beacon Pharma Ltd. in Bangladesh.

Non-small cell lung cancer (NSCLC) is a type of lung cancer that accounts for about 80% of all lung cancer cases. Here a...
18/02/2023

Non-small cell lung cancer (NSCLC) is a type of lung cancer that accounts for about 80% of all lung cancer cases. Here are some facts about non-small cell lung cancer:

✔ NSCLC is the most common type of lung cancer, accounting for about 80-85% of all cases.
✔ There are three main subtypes of NSCLC: adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. Adenocarcinoma is the most common subtype.
✔ Risk factors for NSCLC include smoking, exposure to secondhand smoke, exposure to certain chemicals (such as radon and asbestos), and a family history of lung cancer.
✔ Symptoms of NSCLC can include coughing, chest pain, shortness of breath, hoarseness, weight loss, and fatigue.
✔ Treatment options for NSCLC include surgery, radiation therapy, chemotherapy, targeted therapy, and immunotherapy.
✔ The prognosis for NSCLC depends on the stage of the cancer at the time of diagnosis. Early-stage NSCLC is more treatable than advanced-stage NSCLC.
✔ Prevention strategies for NSCLC include not smoking, avoiding exposure to secondhand smoke, and minimizing exposure to chemicals and other environmental risk factors.
✔ Regular screening with low-dose computed tomography (LDCT) is recommended for people who are at high risk of developing lung cancer, such as heavy smokers.
✔ In recent years, there have been significant advances in the treatment of NSCLC, particularly in the areas of targeted therapy and immunotherapy, which can help to improve outcomes for some patients.
✔ Like other forms of cancer, NSCLC can have a significant impact on patients and their families, both physically and emotionally. Support from healthcare providers, family members, and other caregivers can be important in helping patients cope with the challenges of the disease.
Tagrix is a drug shown to improve survival in patients with advanced non-small cell lung cancer with EGFR mutations...
If you are interested, then contact us on WhatsApp at +880-1922101029 or visit: https://emergencydrug.com/shop/tagrix-osimertinib-80-mg/

Tagrix indicate for the prevent epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC)

Types of non-small cell lung cancer:There are three primary types of NSCLC, categorized by the type of cells affected by...
08/07/2022

Types of non-small cell lung cancer:

There are three primary types of NSCLC, categorized by the type of cells affected by cancer:

➡️ Adenocarcinoma: represents 40 percent of all NSCLC diagnoses. Adenocarcinoma affects both smokers and nonsmokers. Adenocarcinoma usually begins in the outer areas of the lung, in mucus-producing cells that line the small airways, called bronchioles. Adenocarcinoma tends to grow more slowly than other types of lung cancer, which can help lead to a better prognosis.

➡️ Squamous cell carcinoma: also called epidermoid carcinoma, is the second most common type of NSCLC, representing 25 to 30 percent of all NSCLC diagnosis. Squamous cells, thin flat cells lining the surfaces of organs, are found in the lining of the bronchi. These cancers are more likely to spread to other areas of the body, making them more difficult to treat. Squamous cell carcinoma is more closely associated with smoking than any other type of lung cancer.

➡️ Large cell carcinoma: is a rare form of NSCLC, accounting for only 10 to 15 percent of all diagnoses. It can occur anywhere in the lung and tends to be aggressive.

Tagrix is a drug shown to improve survival in patients with advanced non-small cell lung cancer with EGFR mutations.

Treatments for non-small cell lung cancer:Treatment for NSCLC will depend on whether the cancer has spread to other area...
07/07/2022

Treatments for non-small cell lung cancer:

Treatment for NSCLC will depend on whether the cancer has spread to other areas of the body, your overall health and age, and the presence of certain proteins that make treatments more effective. If your NSCLC is detected early (before it has spread to other areas), surgery to remove the affected tissue or tumor is the treatment of choice.

Other treatments include the following:
➡️ Radiation therapy: This uses high-energy rays to kill cancer cells and keep new ones from growing. It can be used to treat cancer that has not metastasized. It may also be used to reduce symptoms and improve your quality of life.
➡️ Chemotherapy: This uses anti-cancer drugs administered either through injection into the vein, or orally (by taking a pill) to kill cancer cells. Chemotherapy can prolong survival and treat symptoms of NSCLC.
➡️ Targeted therapy: This uses anti-cancer drugs to kill specific cancer cells without causing harm to normal cells. These therapies are usually given if you have specific gene mutations, as determined by genetic testing.
➡️ Immunotherapy: This activates your body’s immune system to specifically kill cancer cells and is usually recommended for late-stage lung cancer, specifically Stage IV NSCLC. “When immunotherapy was first introduced, the effects were dramatic,” says Dr. Herbst. “Now we are using combined therapies such as immunotherapy with chemotherapy and exploring other immunotherapy or targeted therapies in combination, and we are seeing results.”

Osimertinib is a medicine that can significantly improve the survival rate for patients with advanced lung cancer with EGFR mutations.

If you are interested, then contact us on WhatsApp at +880-1922101029 or visit: https://emergencydrug.com/shop/tagrix-osimertinib-80-mg/

The development of malignant cells (cancer) in the lung is non-small cell lung cancer. Non-small cell lung cancer is pri...
08/06/2022

The development of malignant cells (cancer) in the lung is non-small cell lung cancer. Non-small cell lung cancer is primarily caused by smoking. The symptoms of non-small cell lung cancer include a cough that won't go away and shortness of breath.

Complications of non-small cell lung cancer:
Lung cancer can spread to different parts of your body, which is known as metastasis. Lung cancer commonly metastasizes to areas such as the brain, bones, liver, and adrenal glands. When cancer spreads, it can lead to undesirable symptoms in the organs it affects.

❌ Pain:
Pain can occur in the chest or anywhere the lung cancer has spread. Typically, pain is felt when the disease has advanced.

❌ Lung Problems:
If cancer blocks your airways, you might experience shortness of breath. Sometimes, breathing difficulties are caused by pleural effusion (fluid buildup around the lungs). When fluid accumulates, it makes it harder for your lungs to expand when you take a breath fully.

❌ Nerve Problems:
Lung cancer can sometimes grow into and damage nerves, resulting in many different types of symptoms, including nerve-related pain, also known as neuropathy. Cancer treatments may also be to blame for this complication.

❌ Heart Issues:
Some lung tumors can grow near the heart or major vessels in your body. When this happens, certain veins and arteries may become blocked, which can cause swelling in the chest, neck, or face.

❌ Swallowing Difficulties:
If cancer grows near the esophagus (the tube connecting your throat to your stomach), you might experience difficulty swallowing. Some people also report feeling more pain when eating or drinking.

Osimertinib is a drug shown to improve survival in patients with advanced non-small cell lung cancer with EGFR mutations.

If you are interested, then contact us on WhatsApp at +880-1922101029 or visit: https://emergencydrug.com/product-tag/osimertinib/

Lung cancer can spread to different parts of your body, which is known as metastasis. Lung cancer commonly metastasizes ...
26/05/2022

Lung cancer can spread to different parts of your body, which is known as metastasis. Lung cancer commonly metastasizes to areas such as the brain, bones, liver, and adrenal glands. When cancer spreads, it can lead to undesirable symptoms in the organs it affects.

➡️ Pain:
Pain can occur in the chest or anywhere the lung cancer has spread. Typically, pain is felt when the disease has advanced.

➡️ Lung Problems:
If cancer blocks your airways, you might experience shortness of breath. Sometimes, breathing difficulties are caused by pleural effusion (fluid buildup around the lungs). When fluid accumulates, it makes it harder for your lungs to expand when you take a breath fully.

➡️ Nerve Problems:
Lung cancer can sometimes grow into and damage nerves, resulting in many different types of symptoms, including nerve-related pain, also known as neuropathy. Cancer treatments may also be to blame for this complication.

➡️ Heart Issues:
Some lung tumors can grow near the heart or major vessels in your body. When this happens, certain veins and arteries may become blocked, which can cause swelling in the chest, neck, or face.

➡️ Swallowing Difficulties:
If cancer grows near the esophagus (the tube connecting your throat to your stomach), you might experience difficulty swallowing. Some people also report feeling more pain when eating or drinking.

Osimertinib is a medicine that can significantly improve the survival rate for patients with advanced lung cancer with EGFR mutations.

If you are interested, then contact us on WhatsApp at +880-1922101029 or visit: https://emergencydrug.com/product-tag/osimertinib/

  is an   growth factor   (EGFR) tyrosine kinase inhibitor (TKI) that binds to certain mutant forms of EGFR (T790M, L858...
16/05/2022

is an growth factor (EGFR) tyrosine kinase inhibitor (TKI) that binds to certain mutant forms of EGFR (T790M, L858R, and exon 19 deletion) that in non-small cell (NSCLC) tumors following with first-line EGFR-TKIs.

Contact with us for order.
WhatsApp: +880 1922-101029

  is indicated for the treatment of patients with metastatic   growth factor receptor ( ) T790M mutation-positive non-sm...
16/01/2022

is indicated for the treatment of patients with metastatic growth factor receptor ( ) T790M mutation-positive non-small cell lung cancer ( ), as detected by an FDA-approved test, whose has progressed on or after EGFR (TKI) .

Contact with us for order.

  is   for the treatment of patients with     growth   receptor (EGFR) T790M mutation-positive non-small cell     (NSCLC...
19/12/2021

is for the treatment of patients with growth receptor (EGFR) T790M mutation-positive non-small cell (NSCLC), as detected by an -approved test, whose has on or after EGFR inhibitor (TKI) .

Contact with us for order.

  is an epidermal growth factor   ( ) tyrosine     (TKI) that binds to certain mutant forms of EGFR (T790M, L858R, and e...
17/07/2021

is an epidermal growth factor ( ) tyrosine (TKI) that binds to certain mutant forms of EGFR (T790M, L858R, and exon 19 deletion) that in non-small ( ) tumors following treatment with first-line EGFR-TKIs.

Inbox us or contact us on Whatsapp for order.

=Is   a  ?  is also used to treat     of   that has spread to other parts of the   in   who could not be treated success...
13/06/2021

=Is a ?

is also used to treat of that has spread to other parts of the in who could not be treated successfully with other . is in a class of medications called

contact with us for order.

Address


Opening Hours

Monday 09:00 - 17:00
Tuesday 09:00 - 17:00
Wednesday 09:00 - 17:00
Thursday 09:00 - 17:00
Saturday 09:00 - 17:00
Sunday 09:00 - 17:00

Telephone

+8801922101029

Alerts

Be the first to know and let us send you an email when Osimertinib posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Osimertinib:

Shortcuts

  • Address
  • Telephone
  • Opening Hours
  • Alerts
  • Contact The Practice
  • Claim ownership or report listing
  • Want your practice to be the top-listed Clinic?

Share